Role of the JAK/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-κB expression

Molecular Medicine Reports

Volumn 7, Issue 1, 2013, Pages 93-98

  Zhang, Song ^a   Liu, Xin ^a   Goldstein, Steven ^b   Li, Yigang ^a   Ge, Junbo ^c   He, Ben ^d   Fei, Xuetao ^a   Wang, Zuyue ^b   Ruiz, George ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c FUDAN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Janus kinase signal transducer and activator of transcription; Myocardial infarction; Nuclear factor B; Signaling pathway; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEART VENTRICLES; JANUS KINASES; MYOCARDIAL INFARCTION; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873857183     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1159     Document Type: Article

References (33)

1. Igaz P, Toth S and Falus A: Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm Res 50: 435-441, 2001.
2. Kisseleva T, Bhattacharya S, Braunstein J and Schindler CW: Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285: 1-24, 2002.
3. Sen R and Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716, 1986.
4. Yeh CH, Chen TP, Wu YC, Lin YM and Jing Lin P: Inhibition of NFkappa B activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res 125: 109-116, 2005.
5. Altavilla D, Deodato B, Campo GM, et al: IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 47: 515-528, 2000.
6. Christman JW, Lancaster LH and Blackwell TS: Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 24: 1131-1138, 1998.
7. Chen J, Jiang H, Yang J, Chen SS and Xu L: Down-regulation of CREB-binding protein expression blocks thrombin-mediated endothelial activation by inhibiting acetylation of NF-kappaB. Int J Cardiol 154: 147-152, 2012.
8. Fan Y, Wang J, Wei L, He B, Wang C and Wang B: Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-kappaB pathway. Int J Cardiol 152: 49-55, 2011.
9. Zhang S, He B, Goldstein S, Ge J, Wang Z and Ruiz G: Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention. Can J Physiol Pharmacol 89: 109-115, 2011.
10. Zhang S, He B, Ge J, Zhai C, Liu X and Liu P: Characterization of chemical composition of Agaricus brasiliensis polysaccharides and its effect on myocardial SOD activity, MDA and caspase-3 level in ischemia-reperfusion rats. Int J Biol Macromol 46: 363-366, 2010.
11. Zhang S, He B, Ge J, et al: Extraction, chemical analysis of Angelica sinensis polysaccharides and antioxidant activity of the polysaccharides in ischemia-reperfusion rats. Int J Biol Macromol 47: 546-550, 2010.
12. Booz GW, Day JN and Baker KM: Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34: 1443-1453, 2002.
13. Strutz F and Muller GA: The role of tubulo-interstitial processes in progression of primary renal diseases. Nephr Dial Transplant 9: 10-20, 1994.
14. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G and Schulz R: The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120: 172-185, 2008.
15. Negoro S, Kunisada K, Tone E, et al: Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res 47: 797-805, 2000.
16. Mascareno E, El-Shafei M, Maulik N, et al: JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104: 325-329, 2001.
17. Heyninck K, Kreike MM and Beyaert R: Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1. FEBS Lett 536: 135-140, 2003.
18. Nair A, Venkatraman M, Maliekal TT, Nair B and Karunagaran D: NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22: 50-58, 2003.
19. Sen R and Baltimore D: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47: 921-928, 1986.
20. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
21. Rodriguez-Porcel M, Lerman LO, Holmes DR Jr, Richardson D, Napoli C and Lerman A: Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res 53: 1010-1018, 2002.
22. Dichtl W, Nilsson L, Goncalves I, et al: Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res 84: 1085-1094, 1999.
23. Ritchie ME: Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 98: 1707-1713, 1998.
24. Kawano S, Kubota T, Monden Y, et al: Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 291: H1337-H1344, 2006.
25. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N and Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72: 3666-3670, 1975.
26. Shaw T, Nixon JS and Bottomley KM: Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis. Expert Opin Investig Drugs 9: 1469-1478, 2000.
27. Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ and Lai LP: Metformin inhibits TNF-alpha-induced Ikappa B kinase phosphorylation, Ikappa B-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int J Cardiol 134: 169-175, 2009.
28. Cao YL, Wang YX, Wang DF, Meng X and Zhang J: Correlation between omental TNF-alpha protein and plasma PAI-1 in obesity subjects. Int J Cardiol 128: 399-405, 2008.
29. Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts C and Vrints CJ: Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J Cardiol 113: 34-38, 2006.
30. Sharma R and Anker SD: Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 85: 161-171, 2002.
31. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S and Braunwald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101: 2149-2153, 2000.
32. Irwin MW, Mak S, Mann DL, et al: Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498, 1999.
33. Held TK, Weihua X, Yuan L, Kalvakolanu DV and Cross AS: Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun 67: 206-212, 1999.